Anti-HSV type 2 Polyclonal antibody[HRP]

We tested whether seropositivity for common pathogens was associated with cognitive impairment among home-dwelling elderly with vascular diseases (n=383). Viral. burden (herpes simplex type 1 (HSV1) type 2 (HSV2), or cytomegalovirus (CMV), and bacterial burden (Chlamydia pneumoniae and Mycoplasma pneumoniae) were measured. Mini-Mental State Examination (MMSE < 24 points) and its changes were used to define cognitive impairment. At baseline, 58 individuals (15.1%) had cognitive impairment which after adjustments was significantly associated with seropositivity for 3 viruses (risk ratio 2.5, 95% CI 1.3 to 4.7). MMSE score decreased in 150 (43%) during 12-month follow-up. After adjustment for baseline MMSE score, the risk ratio of cognitive decline increased with increasing viral burden. No significant associations were observed between bacterial burden and cognition. In conclusion, viral burden of herpesviridae was associated with cognitive impairment in home-dwelling elderly.

OBJECTIVE: The pathway by which herpes simplex virus 2 (HSV2) triggers the innate immune system in the urogenital system has not as yet been fully elucidated. In this study, we aimed to determine which pattern recognition receptors (PRRs) recognize HSV2 in primary vaginal epithelial cells. Once we deciphered the receptors involved, we aimed to target them to immunomodulate innate responses as a prophylactic or therapeutic intervention for early HSV2 infection. STUDY DESIGN: To determine which PRRs are involved, receptor silencing as well as confocal microscopy was utilized. For immuno-modulation, PRR agonists were utilized to induce a strong, local response to limit the infection, and we used 2 quantitative methods, flow cytometry and plaque assays, to determine their effect on HSV2 replication. RESULTS: Our results show that HSV2 is detected by a plethora of PRRs: Toll-like receptors (TLR) 2 as well as deoxyribonucleic acid (DNA) sensors TLR9, DNA-dependent activator of interferon regulatory factors, and to a lesser extent interferon-inducible 16, which trigger cytokine secretion to protect the host. Using PRR agonists, such as lipoproteins, CpG DNA, and cyclic dinucleotides, we could significantly limit HSV2 replication. CONCLUSION: Different PRRs are strategically placed in different cell locations to detect virus invasion. Use of agonists that target and activate these PRRs appeared to be effective in preventing primary HSV2 infection in vaginal cells and could provide new insights in defense against HSV2 urogenital infections.